Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00531518 · ClinicalTrials.gov registry record · NA
Early Detection and Intervention for the Prevention of Psychosis
A NA study of Depression and Schizophrenia, sponsored by MaineHealth.
- Completed
- Registry status
- NA
- Development phase
- 292
- Enrollment target
- 6
- Study locations
NCT00531518 is a NA study of Depression and Schizophrenia that has completed, run by MaineHealth. The registered enrollment target is 292 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT00531518, a NA study of Depression and Schizophrenia, has completed, sponsored by MaineHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 292 participants
- Enrollment target
- 6
- Study locations
Study Summary
EDIPP is a multisite trial of early identification and intervention to prevent the onset of psychosis in adolescents and young adults, carried out at six sites across the United States. The hypothesis is that very early identification and intervention will be effective in delaying or preventing onset of psychosis and improving social and occupational functioning.
Conditions Studied
Interventions
- DRUG aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine
- BEHAVIORAL Psychoeducational multifamily group treatment
- BEHAVIORAL Supported employment and education
Study Locations (6)
California
- University of California-Davis, Imaging Research Center - Sacramento
Maine
- Portland Identification and Early Referral Program - Portland
Michigan
- Washtenaw County - Ann Arbor
New Mexico
- University of New Mexico - Albuquerque
New York
- Zucker Hillside Hosptial - Glen Oaks
Oregon
- Mid-Valley Behavioral Care Network - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2007-10 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00531518
The ClinicalTrials.gov registry entry for NCT00531518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower). The listed sponsor is MaineHealth, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine is the first listed.
NCT00531518 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Maine, Michigan.
Frequently Asked Questions
What is clinical trial NCT00531518 about?
NCT00531518 is a clinical study titled "Early Detection and Intervention for the Prevention of Psychosis". EDIPP is a multisite trial of early identification and intervention to prevent the onset of psychosis in adolescents and young adults, carried out at six sites across the United States. The hypothesis is that very early identification and intervention will be effective in delaying or preventing onse...
What is the current status of trial NCT00531518?
This trial is currently completed. It is a NA study. The enrollment target is 292 participants. The study started on 2007-10. Estimated completion is 2013-09.
What conditions does trial NCT00531518 study?
This clinical trial studies the following conditions: Depression, Schizophrenia, Bipolar Disorder, Psychotic Disorders.
What interventions are being tested in trial NCT00531518?
The interventions under investigation include: aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine (DRUG), Psychoeducational multifamily group treatment (BEHAVIORAL), Supported employment and education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00531518?
This trial is sponsored by MaineHealth, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00531518 being conducted?
This trial has 6 study locations across California, Maine, Michigan, New Mexico, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.